HCA 3rd Quarter 2017 Earnings Conference Call
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/16/2026
- Wall Street futures edge higher in countdown to Fed decision
- Oil slips as Saudi Arabia offers more crude via Oman; diesel near record high
- AI chip sell-off overblown: Zero GPU slowdown after Anthropic essay, analyst says
- Global AI stocks fall as industry chiefs call for slowing development
- Stocks tend to rise after the Fed starts to hike
- U.S. Commerce Department to sell up to 9.9M GlobalFoundries shares
- Wall Street ends lower as oil spikes and the benchmark Treasury yield breaches 5%
- AI chip sell-off overblown: Zero GPU slowdown after Anthropic essay, analyst says
- Stocks tend to rise after the Fed starts to hike
- Raymond James Downgrades Ascendis Pharma (ASND) to Outperform
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
HCA Holdings (HCA) PT Lowered to $90 at Jefferies Following 3Q Pre-Announcement
October 19, 2017 8:48 AM EDTJefferies lowered its price target on HCA Holdings (NYSE: HCA) to $90.00 (from $92.00) while maintaining a Buy rating following the company's 3Q pre-announcement. HCA pre-announced Q3 EBITDA of $1.776B vs. $1.97B consensus. EBITDA was dragged down by the hurricanes ($140MM) and a TX Medicaid... More
